(EMAILWIRE.COM, August 02, 2018 ) Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of real-world data. Real-world data (RWD) is defined as data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings. The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.

Objectives of the Study

To define, describe, and forecast the global real-world evidence market on the basis of component, therapeutic area, end user, and region

To provide detailed information regarding the major factors influencing the growth of the real world evidence solutions market (drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the real world evidence solutions market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World, along with major countries in these regions

To strategically profile the key players and comprehensively analyze their market shares and core competencies in the real-world evidence market

To track and analyze competitive developments such as partnerships, agreements, & collaborations; alliances; mergers & acquisitions; and new service launches in the global real world evidence solutions market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Real World Evidence Solutions Market

To know about the assumptions considered for the study, download the pdf brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=76173991

The prominent players in the global real world evidence market are IQVIA (US), International Business Machines Corporation (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).

Target Audience:

Hospitals and clinics
Insurers
Pharmaceutical and medical device companies
Academic medical centers
Government research organizations
Contract research organizations
Research and consulting firms
Regulatory agencies

Press Release : https://www.prnewswire.com/news-releases/rwe-analytics-a-key-to-optimize-drug-failure-rates-and-cost-of-drug-development-842320977.html

Scope of the Report:

The research report categorizes the market into the following segments and subsegments:

Real World Evidence Market, By Component

Introduction
Data Sets
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
Services
Real World Evidence Market, By Therapeutic Area

Oncology
Cardiovascular Disease
Neurology
Immunology
Others Therapeutic Areas
Real World Evidence Market, By End User

Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users
Real world evidence Market, By Region

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest Of Europe
Asia Pacific (APAC)
China
Japan
Rest of APAC
Rest of the World